ACHIEVE LIFE SCIENCES, INC. (ACHV)

↓ Download CSV

CIK 0000949858 · Nasdaq · In Vitro & In Vivo Diagnostic Substances

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-254.0%
Return on equity
Metric (FY)2025202420232022202120202019201820172016
Revenue$0$0
Net Income-$54.65M-$39.83M-$29.82M-$42.35M-$33.15M-$14.73M-$16.39M-$12.69M-$10.58M-$1.23M
EPS (Diluted)$-1.25$-1.24$-1.50$-4.00$-4.08$-5.42
Total Assets$41.79M$38.63M$19.37M$29.97M$47.52M$40.30M$21.08M$19.08M$9.89M$3.81M
Total Liabilities$20.27M$17.73M$20.82M$21.67M$19.47M$3.01M$3.03M$3.28M$2.01M$3.20M
Shareholders' Equity$21.52M$20.90M-$1.45M$8.30M$28.04M$37.29M$18.05M$15.80M$15.80M$610.0K
Cash & Equivalents$20.93M$12.75M$15.55M$24.77M$43.02M$35.85M$16.66M$9.52M$5.28M$15.0K
Operating Cash Flow-$49.47M-$29.77M-$24.48M-$37.57M-$29.44M-$13.47M-$15.22M-$10.62M-$9.11M-$202.0K
Capital Expenditures$3.0K$21.0K$17.0K$53.0K$46.0K$46.0K
Shares Outstanding53.23M34.69M21.17M17.90M9.45M6.11M1.47M6.72M1.19M21.2K